- Home
- CLH vs HOLX Comparison
CLH vs HOLX Comparison
Compare CLH & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLH
- HOLX
- Stock Information
- Founded
- CLH 1980
- HOLX 1985
- Country
- CLH United States
- HOLX United States
- Employees
- CLH N/A
- HOLX N/A
- Industry
- CLH Environmental Services
- HOLX Medical Electronics
- Sector
- CLH Industrials
- HOLX Health Care
- Exchange
- CLH Nasdaq
- HOLX Nasdaq
- Market Cap
- CLH 12.7B
- HOLX 16.5B
- IPO Year
- CLH 1987
- HOLX 1990
- Fundamental
- Price
- CLH $205.43
- HOLX $74.17
- Analyst Decision
- CLH Buy
- HOLX Hold
- Analyst Count
- CLH 10
- HOLX 15
- Target Price
- CLH $252.90
- HOLX $79.00
- AVG Volume (30 Days)
- CLH 720.2K
- HOLX 4.7M
- Earning Date
- CLH 10-29-2025
- HOLX 11-03-2025
- Dividend Yield
- CLH N/A
- HOLX N/A
- EPS Growth
- CLH N/A
- HOLX N/A
- EPS
- CLH 7.20
- HOLX 2.49
- Revenue
- CLH $5,962,257,000.00
- HOLX $4,100,500,000.00
- Revenue This Year
- CLH $2.95
- HOLX $6.23
- Revenue Next Year
- CLH $4.16
- HOLX $5.37
- P/E Ratio
- CLH $28.50
- HOLX $29.81
- Revenue Growth
- CLH 2.85
- HOLX 1.74
- 52 Week Low
- CLH $178.29
- HOLX $51.90
- 52 Week High
- CLH $265.72
- HOLX $81.13
- Technical
- Relative Strength Index (RSI)
- CLH 28.61
- HOLX 70.81
- Support Level
- CLH $205.84
- HOLX $73.86
- Resistance Level
- CLH $248.07
- HOLX $74.28
- Average True Range (ATR)
- CLH 6.54
- HOLX 0.36
- MACD
- CLH -3.53
- HOLX 0.01
- Stochastic Oscillator
- CLH 3.81
- HOLX 83.17
About CLH Clean Harbors Inc.
Clean Harbors Inc is an environmental and industrial services provider. It provides parts cleaning and related environmental services to commercial, industrial, and automotive customers. Its business segments are Environmental Services and Safety-Kleen Sustainability Solutions. The company generates the majority of its revenues from the Environmental Services segment.
About HOLX Hologic Inc.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.